Schott Pharma Ag & CO Kgaa (1SXP.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 247,583 | 256,460 | 252,326 | 229,841 | 237,051 |
| Cost of Goods | 171,501 | 160,361 | 168,610 | 153,274 | 164,348 |
| Gross Profit | 76,082 | 96,099 | 83,716 | 76,567 | 72,703 |
| Operating Expenses | 34,712 | 35,977 | 34,029 | 40,775 | 18,323 |
| Operating Income | 41,370 | 60,122 | 49,687 | 35,792 | 54,380 |
| Interest Expense | 5,461 | 4,914 | 4,834 | 4,802 | 4,361 |
| Other Income | 5,856 | 4,931 | 5,089 | 4,920 | -4,012 |
| Pre-tax Income | 41,765 | 60,139 | 49,942 | 35,910 | 46,007 |
| Income Tax | 8,089 | 14,412 | 11,348 | 6,925 | 11,816 |
| Net Income Continuous | 33,676 | 45,727 | 38,594 | 28,985 | 34,191 |
| Minority Interests | -121 | -163 | -153 | -91 | -217 |
| Net Income | $33,555 | $45,564 | $38,441 | $28,894 | $33,974 |
| EPS Basic Total Ops | 0.22 | 0.30 | 0.26 | 0.19 | 0.22 |
| EPS Basic Continuous Ops | 0.22 | 0.30 | 0.26 | 0.19 | 0.22 |
| EPS Diluted Total Ops | 0.22 | 0.30 | 0.26 | 0.19 | 0.22 |
| EPS Diluted Continuous Ops | 0.22 | 0.30 | 0.26 | 0.19 | 0.22 |
| EBITDA(a) | $69,320 | $84,778 | $73,862 | $59,247 | $68,369 |